These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 23812966

  • 1. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N, Georgieva M, Laleva M, Uzunov K, Miloshev G.
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [Abstract] [Full Text] [Related]

  • 2. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J, Gao G, Wang L, Wang T, Yu J, Zhao Z.
    Pathol Res Pract; 2011 Nov 15; 207(11):674-9. PubMed ID: 21940111
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J, Deng Y, Yang G, Xie W.
    J Surg Oncol; 2013 Aug 15; 108(2):121-5. PubMed ID: 23813496
    [Abstract] [Full Text] [Related]

  • 4. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y, Zhong Z, Yuan J, Zhang Z, Wei Q, Song W, Chen H.
    Cancer Epidemiol; 2013 Oct 15; 37(5):697-702. PubMed ID: 23870768
    [Abstract] [Full Text] [Related]

  • 5. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.
    Yamaguchi S, Kobayashi H, Terasaka S, Ishii N, Ikeda J, Kanno H, Nishihara H, Tanaka S, Houkin K.
    Jpn J Clin Oncol; 2012 Apr 15; 42(4):270-7. PubMed ID: 22399670
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C, Guan Y, Zhao K, Chen L, Bao Y, Cui R, Li G, Wang Y.
    Int J Clin Exp Pathol; 2015 Apr 15; 8(5):4943-52. PubMed ID: 26191187
    [Abstract] [Full Text] [Related]

  • 7. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
    Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S, Glioma Outcomes Investigators.
    J Neurosurg; 2003 Sep 15; 99(3):467-73. PubMed ID: 12959431
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L, He S, Tu Y, Ji P, Zong J, Zhang J, Feng F, Zhao J, Gao G, Zhang Y.
    J Clin Neurosci; 2013 Jul 15; 20(7):958-63. PubMed ID: 23707602
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R, Vural M, Işildi E, Coşan E, Ozkara E, Bal C, Ciftçi E, Arslantaş A, Atasoy MA.
    Turk Neurosurg; 2008 Oct 15; 18(4):336-44. PubMed ID: 19107679
    [Abstract] [Full Text] [Related]

  • 10. Glycosphingolipid component profiles or human gliomas--correlation to survival time and histopathological malignancy grading.
    Becker R, Rohlfs J, Jennemann R, Wiegandt H, Mennel HD, Bauer BL.
    Clin Neuropathol; 2000 Oct 15; 19(3):119-25. PubMed ID: 14606584
    [Abstract] [Full Text] [Related]

  • 11. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C, Shi H, Wang C, Wang J, Geng N, Jiang X, Wang X.
    Neurosci Lett; 2012 Dec 07; 531(2):204-8. PubMed ID: 23103713
    [Abstract] [Full Text] [Related]

  • 12. A multivariate analysis of the prognostic factors of grade III gliomas.
    Zhu YJ, Zhu XD, Wang SH, Shen F, Shen H, Liu WG.
    Chin Med J (Engl); 2008 Jun 20; 121(12):1072-5. PubMed ID: 18706219
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
    Schittenhelm J, Schwab EI, Sperveslage J, Tatagiba M, Meyermann R, Fend F, Goodman SL, Sipos B.
    J Neuropathol Exp Neurol; 2013 Mar 20; 72(3):194-210. PubMed ID: 23399898
    [Abstract] [Full Text] [Related]

  • 14. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B, Pang B, Hou X, Fan H, Liang N, Zheng S, Feng B, Liu W, Guo H, Xu S, Pang Q.
    Hum Pathol; 2014 Aug 20; 45(8):1752-8. PubMed ID: 24935062
    [Abstract] [Full Text] [Related]

  • 15. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
    Sun ZF, Wang L, Gu F, Fu L, Li WL, Ma YJ.
    Zhonghua Zhong Liu Za Zhi; 2012 Jan 20; 34(1):26-30. PubMed ID: 22490851
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS, Dong QS, Ding H, Miao ZL, Lin YC.
    J Clin Neurosci; 2014 May 20; 21(5):755-60. PubMed ID: 24382515
    [Abstract] [Full Text] [Related]

  • 17. Extent of resection and survival in supratentorial infiltrative low-grade gliomas: analysis of and adjustment for treatment bias.
    Gousias K, Schramm J, Simon M.
    Acta Neurochir (Wien); 2014 Feb 20; 156(2):327-37. PubMed ID: 24264163
    [Abstract] [Full Text] [Related]

  • 18. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
    Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X, Wang B.
    Jpn J Clin Oncol; 2010 May 20; 40(5):388-94. PubMed ID: 20304779
    [Abstract] [Full Text] [Related]

  • 19. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
    Devaux BC, O'Fallon JR, Kelly PJ.
    J Neurosurg; 1993 May 20; 78(5):767-75. PubMed ID: 8468607
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic value of epileptic seizures in patients with cerebral gliomas].
    Krzyszkowski T, Czepko R, Betlej M.
    Ann Acad Med Stetin; 2004 May 20; 50(1):35-40. PubMed ID: 16871742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.